Carbocisteine Suppliers & Bulk Manufacturers
Available Forms: Capsules, Oral Solutions/Syrups
Available Strengths: Cap: 375 mg and 750 mg; Oral Solution: 50 mg/5 mL and 750 mg/5 mL
Reference Brands: Mucodyne, Lisomucil®, Rhinathiol®, Muciclar®, Actithiol®, Mucolex®(US)
Category:
Respiratory Disorder
Carbocisteine is a mucolytic used in Europe to treat COPD, bronchitis, and other respiratory conditions. Available as 375 mg/750 mg capsules and 250 mg/5 mL or 750 mg/5 mL syrups, it's sold under brands like Mucodyne® and Rhinathiol®. Ideal for B2B, PCD, and export markets.
Carbocisteine is available in Capsules, Oral Solutions/Syrups
and strengths such as Cap: 375 mg and 750 mg; Oral Solution: 50 mg/5 mL and 750 mg/5 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Carbocisteine is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Carbocisteine can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Carbocisteine is a widely used mucolytic agent in Europe, effective in managing respiratory conditions like COPD, bronchitis, and bronchiectasis by thinning mucus and improving airway clearance. Available in 375 mg and 750 mg capsules and syrups (250 mg/5 mL, 750 mg/5 mL), it is marketed under popular brands such as Mucodyne®, Lisomucil®, Rhinathiol®, and Muciclar®. Though not approved in the US, Carbocisteine is in high demand across EU and Asia, making it a strong option for pharma B2B, PCD franchise, and export business. Its proven efficacy in respiratory care ensures consistent demand across seasonal and chronic markets.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing